Suchergebnisse - "Hulin, C."

PubPharm (126)

1

Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma : the REMIX study

enthalten in: Annals of hematology | 2023

von Macro, M. | Hulin, C. | Vincent, L. | +14

2

Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study

enthalten in: Annals of hematology | 2023

von Macro, M. | Hulin, C. | Vincent, L. | +14

3

Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study

enthalten in: Annals of hematology | 2023

von Macro, M. | Hulin, C. | Vincent, L. | +14

4

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von Fouquet, G. | Pegourie, B. | Macro, M. | +27

5

Cost-effectiveness of lenalidomide plus dexamethasone vs. bortezomib plus melphalan and prednisone in transplant-ineligible U.S. patients with newly-diagnosed multiple myeloma

enthalten in: Journal of medical economics | 2016

von Usmani, S. | Cavenagh, J. | Belch, A. | +13

6

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma

enthalten in: Annals of oncology | 2016

von Fouquet, G. | Pegourie, B. | Macro, M. | +26

7

Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myelome

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2016

von Royer, B. | Minvielle, S. | Diouf, M. | +25

8

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2016

von Hulin, C. | Belch, A. | Shustik, C. | +26

9

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma

enthalten in: Blood | 2016

von Dejoie, T. | Corre, J. | Caillon, H. | +40

10

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2016

von Hulin, C. | Belch, A. | Shustik, C. | +26

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]